The Effect of Cognitive Behavioural Therapy–Based Psychoeducation on Medication Adherence and Aggression in Individuals Diagnosed With Schizophrenia: an Experimental Study

dc.contributor.author Can, S.Y.
dc.contributor.author Budak, F.K.
dc.date.accessioned 2025-02-15T19:39:17Z
dc.date.accessioned 2025-09-17T14:28:25Z
dc.date.available 2025-02-15T19:39:17Z
dc.date.available 2025-09-17T14:28:25Z
dc.date.issued 2025
dc.description.abstract Introduction: It is known that treatment compliance is low and aggression is higher in individuals diagnosed with schizophrenia compared to the normal population. Cognitive behavioural therapy (CBT) is known to reduce relapse and hospitalisation and increase well-being in individuals diagnosed with schizophrenia. However, there are almost no studies on increasing treatment compliance and decreasing aggression. Aims: This study was conducted to determine how CBT–based psychoeducation affects medication adherence and aggression in individuals diagnosed with schizophrenia. Methods: The study was conducted as a quasi-experimental model with the pre-test–post-test control group with 73 schizophrenic patients (33 experimental, 40 control) between June 2022 and July 2023. Data were collected using the Descriptive Characteristics Form, Morisky Medication Adherence Scale (MMAS) and Buss–Perry Aggression Questionnaire (BPSQ). The schizophrenic patients in the experimental group were given eight sessions of CBT-based psychoeducation, while the schizophrenic patients in the control group were not given any training. The data were analysed using mean, standard deviation, chi-squared test, dependent samples t-test and independent samples t-test. Results: It was determined that the aggression level of the experimental group before the training was 80.51 ± 19.38, and after the CBT-based psychoeducation, it was 73.12 ± 15.28. It was determined that the aggression level of the control group before the training was 84.22 ± 12.13, and after the post-test, it was 85.60 ± 11.72. It was determined that the medication adherence level of the experimental group before the training was 2.75 ± 1.25, and after the CBT-based psychoeducation, it was 3.57 ± 0.67. It was determined that the medication adherence level of the control group before the training was 2.05 ± 1.33, and after the post-test, it was 2.17 ± 1.36. The psychoeducation based on CBT caused a statistically significant difference (p = 0.001) in medication adherence and aggression levels in the experimental group. Discussion: It was determined that CBT applied to individuals diagnosed with schizophrenia was effective on increasing their medication adherence and reducing their aggression. It is recommended for psychiatric nurses to include CBT-based psychoeducation in their nursing practices in order to increase medication adherence and reduce aggression in individuals with schizophrenia. Implications for Practice: The findings emphasise that CBT-based psychoeducation increases treatment adherence and significantly decreases the level of aggression in individuals diagnosed with schizophrenia. Psychiatric nurses should include CBT-based psychoeducation in their treatments. © 2024 The Author(s). Journal of Psychiatric and Mental Health Nursing published by John Wiley & Sons Ltd. en_US
dc.identifier.doi 10.1111/jpm.13127
dc.identifier.issn 1351-0126
dc.identifier.issn 1365-2850
dc.identifier.scopus 2-s2.0-86000430251
dc.identifier.uri https://doi.org/10.1111/jpm.13127
dc.identifier.uri https://hdl.handle.net/20.500.12514/9596
dc.language.iso en en_US
dc.publisher John Wiley and Sons Inc en_US
dc.relation.ispartof Journal of Psychiatric and Mental Health Nursing en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Psychoeducation en_US
dc.subject Aggression en_US
dc.subject Cbt en_US
dc.subject Medication Adherence en_US
dc.subject Psychiatric Nursing en_US
dc.subject Schizophrenia en_US
dc.title The Effect of Cognitive Behavioural Therapy–Based Psychoeducation on Medication Adherence and Aggression in Individuals Diagnosed With Schizophrenia: an Experimental Study en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.endpage 456
gdc.description.scopusquality Q1
gdc.description.startpage 445
gdc.description.volume 32
gdc.description.wosquality Q1
gdc.identifier.openalex W4403733855
gdc.identifier.pmid 39445584
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.accesstype HYBRID
gdc.oaire.diamondjournal false
gdc.oaire.impulse 3.0
gdc.oaire.influence 2.6456306E-9
gdc.oaire.isgreen true
gdc.oaire.keywords Original Article
gdc.oaire.keywords Aggression
gdc.oaire.keywords Adult
gdc.oaire.keywords Male
gdc.oaire.keywords Young Adult
gdc.oaire.keywords Cognitive Behavioral Therapy
gdc.oaire.keywords Patient Education as Topic
gdc.oaire.keywords Schizophrenia
gdc.oaire.keywords Humans
gdc.oaire.keywords Female
gdc.oaire.keywords Middle Aged
gdc.oaire.keywords Medication Adherence
gdc.oaire.keywords Antipsychotic Agents
gdc.oaire.popularity 4.6477537E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration National
gdc.openalex.fwci 1.79241947
gdc.openalex.normalizedpercentile 0.76
gdc.opencitations.count 0
gdc.plumx.mendeley 36
gdc.plumx.scopuscites 3
gdc.scopus.citedcount 3
gdc.virtual.author Yaşar Can, Sevinç
relation.isAuthorOfPublication 8ceb2958-5fef-40f9-96f1-5bf32a91b35e
relation.isAuthorOfPublication.latestForDiscovery 8ceb2958-5fef-40f9-96f1-5bf32a91b35e
relation.isOrgUnitOfPublication 39ccb12e-5b2b-4b51-b989-14849cf90cae
relation.isOrgUnitOfPublication.latestForDiscovery 39ccb12e-5b2b-4b51-b989-14849cf90cae

Files